Hookipa Pharma (HOOK) Expected to Announce Quarterly Earnings on Friday

Hookipa Pharma (NASDAQ:HOOK) will likely be announcing its earnings results before the market opens on Friday, March 28th. Analysts expect the company to announce earnings of ($0.41) per share and revenue of $3.44 million for the quarter.

Hookipa Pharma Trading Up 0.8 %

NASDAQ:HOOK opened at $1.23 on Friday. The company has a 50-day moving average price of $1.70 and a 200-day moving average price of $2.78. Hookipa Pharma has a 12 month low of $1.11 and a 12 month high of $10.50. The stock has a market cap of $14.83 million, a price-to-earnings ratio of -0.33 and a beta of 0.71.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on HOOK shares. Royal Bank of Canada cut shares of Hookipa Pharma from an “outperform” rating to a “sector perform” rating and dropped their target price for the stock from $48.00 to $2.00 in a research report on Friday, December 20th. HC Wainwright reiterated a “neutral” rating on shares of Hookipa Pharma in a research note on Friday, January 10th. Finally, JMP Securities decreased their price target on Hookipa Pharma from $24.00 to $7.00 and set a “market outperform” rating for the company in a research note on Thursday, November 21st.

Hookipa Pharma Company Profile

HOOKIPA Pharma Inc, a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors.